首頁 > 市場調查報告書 > 製藥

再生醫學細胞療法

市場調查報告書

商品編碼

1469785

全球富血小板血漿和幹細胞脫髮治療市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年04月01日 | 出版商:

Value Market Research | 英文 175 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計全球富血小板血漿和幹細胞脫髮治療市場的市場規模將從2023年的4.3501億美元增至2032年的近7.281億美元，2024-2032年研究期間的複合年成長率為5.89%。

富含血小板血漿和幹細胞脫髮治療是一種再生療法，旨在刺激脫髮或稀疏個體的頭髮生長並提高頭髮密度。這種治療包括從患者自身的血液或脂肪組織中收集富含血小板的血漿（PRP）和幹細胞，並將它們注射到頭皮中。 PRP 和幹細胞含有促進組織再生和毛囊增殖的生長因子和細胞因子，有可能恢復受脫髮影響的區域的毛髮生長。

市場動態

富血小板血漿（PRP）和幹細胞脫髮治療市場在幾個關鍵因素的推動下正在經歷顯著成長。一個主要促進因素是脫髮疾病的盛行率不斷增加，包括斑禿和雄性禿，人口老化、荷爾蒙失衡和生活方式因素加劇了這一現象。 PRP 和幹細胞療法透過刺激毛囊再生和促進頭髮生長，為頭髮修復提供了有前景的解決方案。此外，對非侵入性和自然毛髮修復療法的需求不斷成長，以及 PRP 和幹細胞療法的有效性和安全性，推動了市場的採用。此外，再生醫學技術的進步，包括細胞分離、加工和輸送方法，可增強治療效果並擴大市場機會。

此外，消費者對整容手術意識的不斷提高以及美容治療中再生醫學方法的日益接受也推動了市場需求。此外，專業診所和美容中心擴大提供 PRP 和幹細胞脫髮治療，這推動了可及性和可負擔性。此外，主要美容和再生醫學參與者之間的策略合作、夥伴關係和投資促進了研發活動，從而推動了市場創新和成長。然而，有限的長期療效資料、監管限制和報銷限制可能會阻礙市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球富血小板血漿和幹細胞脫髮治療市場的各個細分市場進行了包容性評估。富含血小板血漿和幹細胞脫髮治療行業的成長和趨勢為本研究提供了整體方法。

市場區隔

富血小板血漿和幹細胞脫髮治療市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按治療

富血小板血漿治療
幹細胞治療
骨髓
脂肪

按指示

雄性禿
先天性脫髮
疤痕性或疤痕性脫髮
其他

按最終用戶

醫院
皮膚科診所
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的富血小板血漿和幹細胞脫髮治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。富血小板血漿和幹細胞脫髮治療市場的主要參與者包括 Kerastem、Eclipse、Regen Lab SA、Restore Hair、RepliCel Life Sciences、Histogen Inc.、Glofinn Oy。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：富血小板血漿和幹細胞脫髮治療公司的競爭格局

富血小板血漿和幹細胞脫髮治療市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
Kerastem

公司簡介
公司收入
產品
最近的發展

Eclipse

公司簡介
公司收入
產品
最近的發展

Regen Lab SA

公司簡介
公司收入
產品
最近的發展

Restore Hair

公司簡介
公司收入
產品
最近的發展

RepliCel Life Sciences

公司簡介
公司收入
產品
最近的發展

Histogen Inc.

公司簡介
公司收入
產品
最近的發展

Glofinn Oy

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112114204

The global demand for Platelet Rich Plasma and Stem Cell Alopecia Treatment Market is presumed to reach the market size of nearly USD 728.1 Million by 2032 from USD 435.01 Million in 2023 with a CAGR of 5.89% under the study period 2024 - 2032.

Platelet rich plasma and stem cell alopecia treatment is a regenerative therapy aimed at stimulating hair growth and improving hair density in individuals experiencing hair loss or thinning. This treatment involves harvesting platelet-rich plasma (PRP) and stem cells from the patient's own blood or adipose tissue and injecting them into the scalp. PRP and stem cells contain growth factors and cytokines that promote tissue regeneration and hair follicle proliferation, potentially restoring hair growth in areas affected by alopecia.

MARKET DYNAMICS

The platelet-rich plasma (PRP) and stem cell alopecia treatment market is witnessing significant growth driven by several key factors. One primary driver is the increasing prevalence of hair loss disorders, including alopecia areata & androgenetic alopecia, fueled by an aging population, hormonal imbalances, and lifestyle factors. PRP and stem cell-based treatments offer promising solutions for hair restoration by stimulating hair follicle regeneration and promoting hair growth. Moreover, the growing demand for noninvasive and natural hair restoration therapies and the effectiveness and safety profile of PRP and stem cell treatments drive market adoption. Additionally, advancements in regenerative medicine techniques, including cell isolation, processing, and delivery methods, enhance treatment outcomes and expand market opportunities.

Furthermore, the rising consumer awareness of cosmetic procedures and the growing acceptance of regenerative medicine approaches in aesthetic treatments fuel market demand. Moreover, the increasing availability of PRP and stem cell alopecia treatments in specialized clinics and aesthetic centers is driving accessibility and affordability. Furthermore, strategic collaborations, partnerships, and investments among key aesthetic and regenerative medicine players foster research and development activities, thereby driving market innovation and growth. However, limited long-term efficacy data, regulatory constraints, and reimbursement limitations may hinder market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of platelet rich plasma and stem cell alopecia treatment. The growth and trends of platelet rich plasma and stem cell alopecia treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the platelet rich plasma and stem cell alopecia treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Treatment

Platelet Rich Plasma Therapy
Stem Cell Therapy
Bone Marrow
Adipose

By Indication

Androgenic Alopecia
Congenital Alopecia
Cicatricial Or Scarring Alopecia
Others

By End-User

Hospitals
Dermatology Clinics
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Platelet Rich Plasma and Stem Cell Alopecia Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Platelet Rich Plasma and Stem Cell Alopecia Treatment market include Kerastem, Eclipse, Regen Lab SA, Restore Hair, RepliCel Life Sciences, Histogen Inc., Glofinn Oy. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Treatment
- 3.7.2 Market Attractiveness Analysis By Indication
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT MARKET ANALYSIS BY TREATMENT

5.1 Overview by Treatment
5.2 Historical and Forecast Data
5.3 Analysis by Treatment
5.4 Platelet Rich Plasma Therapy Historic and Forecast Sales by Regions
5.5 Stem Cell Therapy Historic and Forecast Sales by Regions
5.6 Bone Marrow Historic and Forecast Sales by Regions
5.7 Adipose Historic and Forecast Sales by Regions

6 . GLOBAL PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT MARKET ANALYSIS BY INDICATION

6.1 Overview by Indication
6.2 Historical and Forecast Data
6.3 Analysis by Indication
6.4 Androgenic Alopecia Historic and Forecast Sales by Regions
6.5 Congenital Alopecia Historic and Forecast Sales by Regions
6.6 Cicatricial or Scarring Alopecia Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT MARKET ANALYSIS BY END-USER

7.1 Overview by End-user
7.2 Historical and Forecast Data
7.3 Analysis by End-user
7.4 Hospitals Historic and Forecast Sales by Regions
7.5 Dermatology Clinics Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT COMPANIES

9.1. Platelet Rich Plasma And Stem Cell Alopecia Treatment Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Kerastem
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Eclipse
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Regen Lab SA
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Restore Hair
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. RepliCel Life Sciences
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Histogen Inc.
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Glofinn Oy
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers : Impact Analysis
Restraints : Impact Analysis
List of Raw Material
List of Raw Material Manufactures
List of Potential Buyers
Analysis by Treatment (USD MN)
Platelet Rich Plasma Therapy Market Sales by Geography (USD MN)
Stem Cell Therapy Market Sales by Geography (USD MN)
Bone Marrow Market Sales by Geography (USD MN)
Adipose Market Sales by Geography (USD MN)
Analysis Market by Indication (USD MN)
Androgenic Alopecia Market Sales by Geography (USD MN)
Congenital Alopecia Market Sales by Geography (USD MN)
Cicatricial or Scarring Alopecia Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Analysis by End-user (USD MN)
Hospitals Market Sales by Geography (USD MN)
Dermatology Clinics Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Platelet Rich Plasma And Stem Cell Alopecia Treatment Market Sales by Geography (USD MN)
North America Market Analysis (USD MN)
United State Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate by Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Platelet Rich Plasma And Stem Cell Alopecia Treatment Report
Market Research Process
Market Research Methodology
Global Platelet Rich Plasma And Stem Cell Alopecia Treatment Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Treatment
Market Attractiveness Analysis by Indication
Market Attractiveness Analysis by End-user
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Treatment (USD MN)
Platelet Rich Plasma Therapy Market Sales by Geography (USD MN)
Stem Cell Therapy Market Sales by Geography (USD MN)
Bone Marrow Market Sales by Geography (USD MN)
Adipose Market Sales by Geography (USD MN)
Global Market Analysis by Indication (USD MN)
Androgenic Alopecia Market Sales by Geography (USD MN)
Congenital Alopecia Market Sales by Geography (USD MN)
Cicatricial or Scarring Alopecia Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Market Analysis by End-user (USD MN)
Hospitals Market Sales by Geography (USD MN)
Dermatology Clinics Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis